Evidence map›Paper›PMID 38665663›Full record

ArticleJACS Au2024

Extended Quinolizinium-Fused Corannulene Derivatives: Synthesis and Properties.

Lin Huang, Qing Wang, Peng Fu, Yuzhu Sun, Jun Xu, Duncan L Browne, Jianhui Huang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JACS Au, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Lin HuangSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, P. R. China.
Qing WangSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, P. R. China.ORCID https://orcid.org/0000-0002-1155-2340
Peng FuSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, P. R. China.
Yuzhu SunSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, P. R. China.
Jun XuSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, P. R. China.ORCID https://orcid.org/0000-0002-2562-2872
Duncan L BrowneDepartment of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London (UCL), 29-39 Brunswick Square, Bloomsbury, London WC1N 1AX, U.K.ORCID https://orcid.org/0000-0002-8604-229X
Jianhui HuangSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, P. R. China.ORCID https://orcid.org/0000-0001-7281-663X
Tianjin University · CNMedway School of Pharmacy · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reported here is the design and synthesis of a novel class of extended quinolizinium-fused corannulene derivatives with curved geometry. These intriguing molecules were synthesized through a rationally designed synthetic strategy, utilizing double Skraup-Doebner-Von Miller quinoline synthesis and a rhodium-catalyzed C-H activation/annulation (CHAA) as the key steps. Single-crystal X-ray analysis revealed a bowl depth of 1.28-1.50 Å and a unique "windmill-like" shape packing of

Identifiers

PMID38665663
PMCPMC11040561
OpenAlexW4393247282

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.